In a stunning medical breakthrough, scientists used customized CRISPR gene editing to save a baby’s life from a rare, previously incurable liver disorder—CPS1 deficiency—just six months after birth. This marks the first time a tailored gene therapy has been safely delivered to a human patient, rewriting the infant's DNA directly inside liver cells.